Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug;14(4):247-255.
doi: 10.1159/000500999. Epub 2019 Jul 30.

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019

Affiliations
Review

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019

Marc Thill et al. Breast Care (Basel). 2019 Aug.

Abstract

Every year the Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO), a group of gynecological oncologists specialized in breast cancer and interdisciplinary members specialized in pathology, radiologic diagnostics, medical oncology, and radiation oncology, prepares and updates evidence-based recommendations for the diagnosis and treatment of patients with early and metastatic breast cancer. Every update is performed according to a documented rule-fixed algorithm, by thoroughly reviewing and scoring the recent publications for their scientific validity and clinical relevance. This current publication presents the 2019 update on the recommendations for metastatic breast cancer.

Keywords: AGO grades of recommendation; Bone health; Early and metastatic breast cancer; Locoregional recurrence; Oxford level of evidence; Therapy.

PubMed Disclaimer

Conflict of interest statement

The conflict of interest statements of all authors with conflicts of interest can be found in the supplementary material (see www.karger.com/doi/10.1159/000500999).

Figures

Fig. 1
Fig. 1
Adjuvant bone-targeted therapy for improvement of prognosis.
Fig. 2
Fig. 2
Surgery of chest wall recurrence after mastectomy/axillary recurrence.
Fig. 3
Fig. 3
Endocrine-based treatment options for postmenopausal patients with HER2-negative metastatic breast cancer.
Fig. 4
Fig. 4
Treatment of triple-negative metastatic breast cancer independent of genomic BRCA 1/2 mutation.

References

    1. www.cebm.net.
    1. www.ago-online.de.
    1. Clark EM, Durup D. Inflammatory eye reactions with bisphosphonates and other osteoporosis medications: what are the risks? Ther Adv Musculoskelet Dis. 2015 Feb;7((1)):11–6. - PMC - PubMed
    1. Van Poznak C, Somerfield MR, Barlow WE, Biermann JS, Bosserman LD, Clemons MJ, et al. Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update. J Clin Oncol. 2017 Dec;35((35)):3978–86. - PubMed
    1. Chi MS, Yang KL, Chang YC, Ko HL, Lin YH, Huang SC, et al. Comparing the Effectiveness of Combined External Beam Radiation and Hyperthermia Versus External Beam Radiation Alone in Treating Patients With Painful Bony Metastases: A Phase 3 Prospective, Randomized, Controlled Trial. Int J Radiat Oncol Biol Phys. 2018 Jan;100((1)):78–87. - PubMed